CRAIG W KUEBKER

Allopathic & Osteopathic Physicians|Family Medicine SAN ANTONIO, TX NPI 1780651968

General Payments — all program years on this page

$2,239.85

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 125
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $305.63 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $305.6310

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $124.991
Abbott Laboratories $44.302
Acerta Pharma LLC $33.192
Astellas Pharma US Inc $28.421
Azurity Pharmaceuticals, Inc. $24.591
PFIZER INC. $18.261
Novo Nordisk AS $17.321
GlaxoSmithKline, LLC. $14.561

By program year

Program yearAmountRecords
2018 $892.1145
2019 $359.4524
2020 $176.5212
2021 $176.3911
2022 $79.525
2023 $250.2318
2024 $305.6310

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096840940 Novo Nordisk Inc $17.32 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104314978 AstraZeneca Pharmaceuticals LP $18.15 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104683767 AstraZeneca Pharmaceuticals LP $15.04 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116501687 GlaxoSmithKline, LLC. $14.56 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125269313 Abbott Laboratories $22.60 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125269315 Abbott Laboratories $21.70 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131990711 PFIZER INC. $18.26 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134008349 Azurity Pharmaceuticals, Inc. $24.59 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136124441 Lilly USA, LLC $124.99 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139421023 Astellas Pharma US Inc $28.42 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.